[HTML][HTML] Beyond PI3Ks: targeting phosphoinositide kinases in disease
JE Burke, J Triscott, BM Emerling… - Nature Reviews Drug …, 2023 - nature.com
Lipid phosphoinositides are master regulators of almost all aspects of a cell's life and death
and are generated by the tightly regulated activity of phosphoinositide kinases. Although …
and are generated by the tightly regulated activity of phosphoinositide kinases. Although …
PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases
Lipid phosphoinositides are master regulators of multiple cellular functions. Misregulation of
the activity of the lipid kinases that generate phosphoinositides is causative of human …
the activity of the lipid kinases that generate phosphoinositides is causative of human …
[HTML][HTML] Apolipoproteins L1 and L3 control mitochondrial membrane dynamics
L Lecordier, P Heo, JH Graversen, D Hennig… - Cell reports, 2023 - cell.com
Summary Apolipoproteins L1 and L3 (APOLs) are associated at the Golgi with the
membrane fission factors phosphatidylinositol 4-kinase-IIIB (PI4KB) and non-muscular …
membrane fission factors phosphatidylinositol 4-kinase-IIIB (PI4KB) and non-muscular …
Structural basis for the conserved roles of PI4KA and its regulatory partners and their misregulation in disease
The type III Phosphatidylinositol 4-kinase alpha (PI4KA) is an essential lipid kinase that is a
master regulator of phosphoinositide signalling at the plasma membrane (PM). It produces …
master regulator of phosphoinositide signalling at the plasma membrane (PM). It produces …
[HTML][HTML] Protein kinase-D1 and downstream signaling mechanisms involved in GLUT4 translocation in cardiac muscle
OS Papur, JFC Glatz, JJFP Luiken - Biochimica et Biophysica Acta (BBA) …, 2024 - Elsevier
Abstract The Ser/Thr kinase protein kinase-D1 (PKD1) is involved in induction of various cell
physiological processes in the heart such as myocellular hypertrophy and inflammation …
physiological processes in the heart such as myocellular hypertrophy and inflammation …
Research progress on phosphatidylinositol 4-kinase inhibitors
G Li, Y Wu, Y Zhang, H Wang, M Li, D He… - Biochemical …, 2023 - Elsevier
Abstract Phosphatidylinositol 4-kinases (PI4Ks) could phosphorylate phosphatidylinositol
(PI) to produce phosphatidylinositol 4-phosphate (PI4P) and maintain its metabolic balance …
(PI) to produce phosphatidylinositol 4-phosphate (PI4P) and maintain its metabolic balance …
DGARM/C10orf76/ARMH3 for Ceramide Transfer Zone at the Endoplasmic Reticulum–Distal Golgi Contacts
Phosphatidylinositol 4-monophosphate (PtdIns (4) P) is one of the key membrane
components which mark the membrane contact sites. In the mammalian Golgi complex …
components which mark the membrane contact sites. In the mammalian Golgi complex …
Investigating how intrinsically disordered regions contribute to protein function using HDX-MS
MAH Parson, ML Jenkins… - Biochemical Society …, 2022 - portlandpress.com
A large amount of the human proteome is composed of highly dynamic regions that do not
adopt a single static conformation. These regions are defined as intrinsically disordered, and …
adopt a single static conformation. These regions are defined as intrinsically disordered, and …
[HTML][HTML] Anionic pulmonary surfactant lipid treatment inhibits rhinovirus A infection of the human airway epithelium
M Numata, S Sajuthi, YA Bochkov, J Loeffler… - Viruses, 2023 - mdpi.com
Rhinoviruses (RVs) are major instigators of acute exacerbations of asthma, COPD, and
other respiratory diseases. RVs are categorized into three species (RV-A, RV-B, and RV-C) …
other respiratory diseases. RVs are categorized into three species (RV-A, RV-B, and RV-C) …
PI4P STimulatING innate immune activation: beyond the Golgi
Y Zheng, X Zhang, C Gao - Cellular & Molecular Immunology, 2023 - nature.com
In a recently published paper titled “ARMH3-mediated recruitment of PI4KB directs Golgi-to-
endosome trafficking and activation of the antiviral effector STING” published in Immunity …
endosome trafficking and activation of the antiviral effector STING” published in Immunity …